Login
Toggle navigation
Videos
Categories
Trending
HTC CEO Peter Chou described the new HTC One as a groundbreaking smartphone with unparalleled design and performance.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Cher Wang serves as the CEO / President of HTC Corp.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Mapping XY Data in Excel with ArcGIS for Excel Add-In
00:10:00
Fabrício Mitre Talks Mitre Realty’s Strategy and Developments One Year After IPO | Fabrício Mitre, CEO , Mitre Realty Empreendimentos e Participações SA.
00:00:00
Bassam Sonbol, M.D. Hematologist / Oncologist, Mayo Clinic
00:10:00
"Excellence in Estate and Business Planning | David Meredith | WealthCounsel"
00:00:00
Glynn Wilson, CEO, TapImmune Inc
00:10:00
Sibanye CEO Neal Froneman Stands Out Among SA Leaders for Embracing Criticism | Neal Froneman, CEO , Sibanye-Stillwater Ltd.
00:10:00
The Future of AI- Using Artificial Intelligence to Anticipate Customers Needs|Tomi Poutanen,Co-Founder and Partner,Radical Ventures
00:10:00
Elmer Stewart on Copper Fox Metals: Copper Market Outlook, Project Details, and Future Plans
00:10:00
Sustainable Energy Initiatives and Collaborative Projects Discussed by CEO | Nicola Monti, CEO, Edison S.p.A.
00:10:00
Dan Goldberg, CEO of Telesat ($TSAT), discusses the company's partnership with MDA as the prime satellite manufacturer for its Lightspeed low Earth orbit constellation.
00:10:00
Investment Partners were formerly with predecessor firm SV Investment Partners|NICHOLAS SOMERS, Managing Partner,SV Investment Partners
00:10:00
The go-to-market plan for BrainChip Holdings' neuromorphic artificial intelligence chips is described | Sean Hehir, CEO, Brainchip Holdings Ltd BRN:ASX